MicroRNA Hsa-miR-125a-3p activates p53 and induces apoptosis in lung cancer cells

Cancer Investigation

Volumn 31, Issue 8, 2013, Pages 538-544

  Jiang, Lili ^a,b   Chang, Jihong ^a,c   Zhang, Qingfu ^a   Sun, Limei ^a   Qiu, Xueshan ^a  

^a Department of Endocrinology   (China)

^b EASTERN LIAONING UNIVERSITY   (China)

^c Siping Central Hospital   (China)

Author keywords

Carcinogenesis; Lung cancer; Tumor biology; Tumor cell Biology; Tumor Suppressors

Indexed keywords

HSA MIR 125A 3P; MESSENGER RNA; MICRORNA; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MICRORNAS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84885090163     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357907.2013.820314     Document Type: Article

References (34)

1. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002;108(2):153-164.
2. Garofalo M, Quintavalle C, Zanca C, De Rienzo A, Romano G, Acunzo M, Puca L, Incoronato M, Croce CM, Condorelli G. Akt regulates drug-induced cell death through Bcl-w downregulation. PLoS One 2008;3(12):e4070.
3. Reed JC. Apoptosis-targeted therapies for cancer. Cancer Cell 2003;3(1):17-22.
4. Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol 2005;205(2):275-292.
5. HollsteinM, Sidransky D, Vogelstein B, Harris CC. p53mutations in human cancers. Science 1991;253(5015):49-53.
6. Soussi T. p53alterations in human cancer: more questions than answers. Oncogene 2007;26(15):2145-2156.
7. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408(6810):307-310.
8. Vousden KH, Lane DP. p53 in health and disease. Nat Rev Mol Cell Biol 2007;8(4):275-283.
9. Oren M. Decision making by p53: life death and cancer. CellDeath Differ 2003;10(4):431-442.
10. Lee RC, Feinbaum RL, Ambros V. The C elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75(5):843-854.
11. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, R?admark O, Kim S, Kim VN. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003;425(6956):415-419
12. Kong W, Zhao JJ, He L, Cheng JQ. Strategies for profiling microRNA expression. J Cell Physiol 2009;218(1):22-25.
13. Kaikkonen MU, Lam MT, Glass CK. Non-coding RNAs as regulators of gene expression and epigenetics. Cardiovasc Res 2011;90(3):430-440.
14. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. A cellular function for the RNA-interference enzyme dicer in the maturation of the let-7 small temporal RNA. Science 2001;293(5531):834-838.
15. Grishok A, Pasquinelli AE, Conte D, Li N, Parrish S, Ha I, Baillie DL, Fire A, Ruvkun G, Mello CC. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C elegans developmental timing. Cell 2001;106(1):23-34.
16. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003;115(2):199-208.
17. OromUA,Nielsen FC, LundAH. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008;30(4):460-471.
18. Janga SC, Vallabhaneni S. MicroRNAs as post-transcriptionalmachines and their interplay with cellular networks. Adv Exp Med Biol 2011;722:59-74.
19. Brennecke J, Stark A, Russell RB, Cohen SM. Principles of microRNA-target recognition. PLoS Biol 2005;3(3):e85.
20. Bartel DP. MicroRNAs genomics biogenesis mechanism and function. Cell 2004;116(2):281-297.
21. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ. A microRNA component of the p53 tumour suppressor network. Nature 2007;447(7148): 1130-1134.
22. Park SY, Lee JH, Ha M, NamJW, KimVN. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nat Struct Mol Biol 2009;16(1):23-29.
23. Fornari F, Gramantieri L, Giovannini C, Veronese A, Ferracin M, Sabbioni S, Calin GA, Grazi GL, Croce CM, Tavolari S, Chieco P, Negrini M, Bolondi L. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 2009;69(14):5761-5767.
24. Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer 2010;10:318.
25. Jiang L, Huang Q, Chang J,Wang E, Qiu X. MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells. Exp Lung Res 2011;37(7):387-398.
26. Gwinn MR, Leonard SS, Sargent LM, Lowry DT, McKinstry K, Meighan T, Reynolds SH, Kashon M, Castranova V, Vallyathan V. The role of p53 in silica-induced cellular and molecular responses associated with carcinogenesis. J Toxicol Environ Health A 2009;72(23):1509-1519.
27. Liu J, ZhengM, Tang YL, Liang XH, YangQ. MicroRNAs an active and versatile group in cancers. Int J Oral Sci 2011;3(4):165-175.
28. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007;302:1-12.
29. Inamura K, Togashi Y, Nomura K, Ninomiya H, Hiramatsu M, Satoh Y, Okumura S, Nakagawa K, Ishikawa Y. let-7 microRNA expression is reduced in bronchioloalveolar carcinoma a noninvasive carcinoma, and is not correlated with prognosis. Lung Cancer 2007;58(3):392-396.
30. Calin GA, Cimmino A, Fabbri M, Ferracin M,Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI, Alder H, Volinia S, Rassenti L, Liu X, Liu CG, Kipps TJ, Negrini M, Croce CM. MiR-15a andmiR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci USA 2008;105(13):5166-5171.
31. Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 2008;54(10): 1696-1704.
32. Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF, Lund E, Dahlberg JE. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 2005;102(10): 3627-3632.
33. Lee I,Ajay SS, Yook JI,Kim HS,Hong SH,KimNH, Dhanasekaran SM, Chinnaiyan AM, Athey BD. New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR interaction sites. Genome Res 2009;19(7):1175-1183.
34. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008;455(7216):1124-1128.